Accessibility settings

This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (1115) Methods and Feasibility Studies (770) HIV/AIDS/STI Prevention and Care (1300) Health Services in Resource-Poor Settings and LMICs (697) Infectious Diseases (non-STD/STI) (1945) Children and Youth with Disabilities (101)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/103274, first published .
Close-up of a person's hands holding a syringe filled with red liquid, labeled "FOR ORAL USE

Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)

Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)

Authors of this article:

Ingrid Courtney1 Author Orcid Image ;   Meredith G Dixon2 Author Orcid Image ;   Louvina van der Laan1 Author Orcid Image ;   Rada Savic3 Author Orcid Image ;   Belen Solans3 Author Orcid Image ;   Kelly Dooley4 Author Orcid Image ;   Deron Burton2 Author Orcid Image ;   Shaun Barnabas5 Author Orcid Image ;   Avy Violari6 Author Orcid Image ;   Kia Bryant2 Author Orcid Image ;   Nigel Scott2 Author Orcid Image ;   Patrick Phillips3 Author Orcid Image ;   Erin Sizemore2 Author Orcid Image ;   Wendy Carr2 Author Orcid Image ;   Susan Purchase1 Author Orcid Image ;   Elri Nortier1 Author Orcid Image ;   Joh-Nell van der Westhuizen1 Author Orcid Image ;   Anne-Marie Demers1 Author Orcid Image ;   Anneke Hesseling1 Author Orcid Image ;   Rosanna Boyd2 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.